Clinical AI Platform for Drug-Resistant TB Nursing Research | QSevidence 2026
Drug-resistant tuberculosis requires sustained medication, visits, psychological support and family coordination. QSevidence can connect patient-support guidance, a nursing intervention and follow-up outcomes into a traceable evidence pathway.
Clinical AI Platform for Drug-Resistant TB Nursing Research | QSevidence 2026
Research question and evidence context
The study compares routine care with an enhanced nursing model comprising tailored education, psychological support, family-community coordination and digital follow-up.
It asks whether the package improves medication adherence, attendance, treatment completion and sputum conversion, and which elements sustain engagement.
Design and outcomes
The plan reports 120 patients randomized 60 per arm. Resistance category, drug regimen, baseline severity, sequence generation, attrition and outcome definitions require verification.
Adherence and completion need explicit denominators and windows. Sputum conversion also needs assay, sampling time and missing-data reporting.
Source facts and verification
| Dimension | Source narrative | Verification |
|---|---|---|
| Sample | 120; 60 per arm | Confirm analysis population |
| Adherence | 91.4% versus 73.2% | Check counts and definitions |
| Completion | 86.2% versus 67.9% | Check follow-up window |
| Sputum conversion | 79.3% versus 62.5% | Check testing time |
Interpreting the reported results
The summary also reports visit attendance of 89.7% versus 71.4%. Several percentages do not correspond neatly to whole-person counts out of 60, so source tables and analysis denominators must be reconciled before publication.
WHO patient-care guidance supports education, treatment support and continuity. Reporting fidelity of each nursing element, reasons for attrition and patient experience would clarify transferability.
QSevidence workflow
- Retrieve drug-resistant TB guidance and nursing-support studies.
- Map each intervention component to medication, visit and treatment outcomes.
- Check counts, denominators, analysis sets and missingness.
- Seek TB, nursing, pharmacy and statistical review.
Practice implications and next steps
A shared follow-up record can capture medication barriers, adverse effects, emotional burden and family support.
Future reports should describe benefit, resource use and applicability across regimens.
Frequently asked questions
How can QSevidence support TB nursing research?
It can organize guidance and studies by population, nursing element, follow-up point and outcome.
How should adherence percentages be interpreted?
First confirm counts, denominators and observation windows, then review attrition and regimen differences.
Can it help plan longitudinal follow-up?
It can map education, dosing, visits, psychosocial support and adverse-event monitoring into a reviewable pathway.
Sources and evidence status
The study design and figures come from the supplied research narrative. They should be checked against original records, complete statistical tables and any final publication. The guidance link provides clinical context, not independent confirmation of the study findings.
Medical research note
This article supports evidence retrieval and research planning. Qualified professionals should make patient-care decisions using individual circumstances, current guidance and local protocols.